Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction

Cancer Journal from Scientific American

Volumn 4, Issue 4, 1998, Pages 237-246

  Posner, Mitchell C ^a,d   Gooding, William E ^b   Landreneau, Rodney J ^a   Rosenstein, Maury M ^c   Clarke, Martha R ^c   Peterson, Mark S ^c   Lembersky, Barry C ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Chemotherapy; Esophageal cancer surgery; Interferon alfa

Indexed keywords

ALPHA2B INTERFERON; CISPLATIN; FLUOROURACIL;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; GASTROINTESTINAL TOXICITY; HEMATOLOGIC DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LOWER ESOPHAGUS SPHINCTER; MALE; MULTIMODALITY CANCER THERAPY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SQUAMOUS CELL CARCINOMA; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; FLUOROURACIL; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 0031902097     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Muller JM, Erasmi H, Stelzner M et al. Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77:845-857.
2. Earlam R, Cunha-Melo J. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980;67:381-390.
3. Earlam R, Cunha-Melo J. Oesophageal squamous cell carcinoma: II. A critical review of radiotherapy. Br J Surg 1980;67:457-461.
4. Urba SG, Orringer MB, Turrist A et al. A randomized trial comparing transhiatal esophagectomy (THE) to preoperative concurrent chemoradiation [CT/XRT] followed by esophagectomy in locoregional esophageal carcinoma [CA]. Proc Am Soc Clin Oncol 1995; 14:199.
5. Walsh TN, Noonan N, Hollywood D et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-510.
6. Forastiere AA, Orringer MB, Perez-Tamayo C et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 1993;11:1118-1123.
7. Bates BA, Detterbeck FC, Bernard SA et al. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996;14:156-163.
8. Naunheim KS, Petruska PJ, Roy TS, et al. Multimodality therapy for adenocarcinoma of the esophagus. Ann Thorac Surg 1995;59: 1085-1091.
9. Sauter ER, Coia LR, Keller SM. Preoperative high-dose radiation and chemotherapy in adenocarcinoma of the esophagus and esophagogastric junction. Ann Surg Oncol 1994;1:5-10.
10. Kavanagh B, Anscher M, Leopold K et al. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990. Int J Radiat Oncol Biol Phys 1992;24:633-642.
11. Stewart JR, Hoff SJ, Johnson DH et al. Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus. Ann Surg 1993;218:571-578.
12. Hoff SJ, Stewart JR, Lawyers JL et al. Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma. Ann Thorac Surg 1993;56:282-287.
13. Forastiere AA, Orringer MB, Perez-Tamayo C et al. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol 1990;8:119-127.
14. Stahl M, Eilke H, Fink U et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: interim analysis of a phase II trial. J Clin Oncol 1996; 14:829-837.
15. Wadler S, Fell S, Haynes H et al. Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferon. Cancer 1993;71:1726-1730.
16. Kelsen D, Lovett D, Wong J et al. Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer. J Clin Oncol 1992;10:269-274.
17. Wadler S, Schwartz EL. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res 1990;50:3473-3486.
18. Wadler S, Haynes H, Beider JJ et al. Phase II clinical trial with 5-fluorouracil, recombinant interferon-alfa-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus. Cancer 1996;78:30-34.
19. Ilson DH, Sirott M, Saltz L et al. A phase II trial of interferon alpha-2a, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma. Cancer 1995;75:2197-2202.
20. van Overhagen H, Lameris JS, Berger MY et al. CT assessment of resectability prior to transhiatal esophagectomy for esophageal/gastroesophageal junction carcinoma. J Comput Assist Tomogr 1993; 17:367-373.
21. Rankin S, Mason R. Review: staging of oesophageal carcinoma. Clin Radiol 1992;46:373-377.
22. Herskovic A, Martz K, Al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-1598.
23. Al-Sarraf M, Martz K, Herskovic A et al: Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 1997;15: 277-284.
24. Duhaylongsod FG, Gottfried MR, Inglehart JD et al. The significance of c-erb B-2 and p53 immunoreactiviry in patients with adenocarcinoma of the esophagus. Ann Surg 1995;221:677-678.
25. Hickey K, Grehan D, Reid IM et al. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy. Cancer 1994;74:1693-1698.
26. Ribeiro U Jr, Safatle-Ribeiro AV, Clarke MR et al. PCNA labeling index as a biomarker of the response to chemoradiotherapy and outcome in patients with esophageal carcinoma. Gastroenterol Suppl 1996;10:A583.
27. Tio TL, Cohen P, Coene PP et al. Endosonography and computed tomography of esophageal carcinoma: preoperative classification compared to the new (1987) TNM system. Gastroenterology 1989;96:1478-1486.
28. Rice TW, Boyce GA, Sivall MV. Esophageal ultrasound and the preoperative staging of carcinoma of the esophagus. J Thorac Cardiovasc Surg 1991;101:536-543.
29. Krasna MJ, Flowers JL, Attar S et al. Combined thoracoscopic/laparoscopic staging of esophageal cancer. J Thorac Cardiovasc Surg 1996;111:800-807.